Good Management and Smart Backing:
"We spoke to the founder, chairman, and CEO of Human Genome Sciences, Dr. William Haseltine, and asked him how investors could analyze a biotech compan's management from their own home. "First," Dr. Haseltine said, "look at the past record of the company's executives. Past success is often the best predictor of future sucess."
Indeed, when investors applied this advice in the past, they were led to many of today's best biotech investments very early. Dr. Haseltine himself helped start 13 different biotech companies, all successful today, before he began HGSI in 1992. He is also world-renown for his research on AIDS. If you knew these facts, you might have bought stock several years ago for pennies on today's dollar.
Amgen's first CEO, George Rathmann, already had a very successful career and was at Abbot Laboratories (ABT) where he was head of diagnostic research. Rathmann led Amgen to its success from 1980 to 1988. He left Amgen to help start up another biotech success, ICOS Corporation. This year, he became CEO of Hyseq, a young company that aims to begin testing its first two drugs on humans in 2001. Maybe you want to consider Hyseq!" |
